Legend Biotech (LEGN) Current Leases (2019 - 2024)
Legend Biotech (LEGN) has disclosed Current Leases for 6 consecutive years, with $4.8 million as the latest value for Q4 2024.
- For the quarter ending Q4 2024, Current Leases rose 50.99% year-over-year to $4.8 million, compared with a TTM value of $4.8 million through Dec 2024, up 50.99%, and an annual FY2024 reading of $4.8 million, up 50.99% over the prior year.
- Current Leases was $4.8 million for Q4 2024 at Legend Biotech, up from $3.2 million in the prior quarter.
- Across five years, Current Leases topped out at $4.8 million in Q4 2024 and bottomed at $911000.0 in Q4 2021.
- Average Current Leases over 5 years is $2.8 million, with a median of $3.2 million recorded in 2023.
- The sharpest move saw Current Leases plummeted 37.77% in 2021, then soared 291.11% in 2022.
- Year by year, Current Leases stood at $1.5 million in 2020, then tumbled by 37.77% to $911000.0 in 2021, then skyrocketed by 291.11% to $3.6 million in 2022, then fell by 10.89% to $3.2 million in 2023, then soared by 50.99% to $4.8 million in 2024.
- Business Quant data shows Current Leases for LEGN at $4.8 million in Q4 2024, $3.2 million in Q4 2023, and $3.6 million in Q4 2022.